Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1432]

Common moles could serve as players in battling melanoma and preventing its recurrence

Common moles could serve as players in battling melanoma and preventing its recurrence

'Suffocating' cancer: A new headway in melanoma immunotherapy

'Suffocating' cancer: A new headway in melanoma immunotherapy

Astronomy meets pathology to identify predictive biomarkers for cancer immunotherapy

Astronomy meets pathology to identify predictive biomarkers for cancer immunotherapy

Analysing tumour microenvironment at single cell level sheds light on metastatic melanoma outcomes

Analysing tumour microenvironment at single cell level sheds light on metastatic melanoma outcomes

ASCO 2021: Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma

ASCO 2021: Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma

ASCO 2021: Benefits of immunotherapy combination persist for more than six years in advanced melanoma

ASCO 2021: Benefits of immunotherapy combination persist for more than six years in advanced melanoma

Study finds way to revive potent immune cells for cancer therapy

Study finds way to revive potent immune cells for cancer therapy

Small uveal melanomas 'not always harmless', ground breaking study finds

Small uveal melanomas 'not always harmless', ground breaking study finds

ASCO 2021: Dual immunotherapy regimen significantly delays disease progression in patients with advanced melanoma

ASCO 2021: Dual immunotherapy regimen significantly delays disease progression in patients with advanced melanoma

Scientists reveal role of genetic switch in pigmentation and melanoma

Scientists reveal role of genetic switch in pigmentation and melanoma

More from ecancer